Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
05/2010
05/05/2010CN101700338A Traditional Chinese medicine for treating asthma
05/05/2010CN101700329A Traditional Chinese medicine for treating wind-heat rhinitis
05/05/2010CN101700307A Traditional Chinese medicine for curing chronic pharyngolaryngitis
05/05/2010CN101700293A Traditional Chinese medicine for curing capillary bronchitis
05/05/2010CN101700282A Traditional Chinese medicine for treating wind-cold rhinitis
05/05/2010CN101700281A Preparation method of mixture medicine of honeysuckle, forsythia and scutellaria baicalensis
05/05/2010CN101700280A Traditional Chinese medicine for treating allergic rhinitis
05/05/2010CN101700279A Traditional Chinese medicine for treating children asthmatic brouchitis
05/05/2010CN101700267A Detection method of persimmon leaf quality
05/05/2010CN101700266A Saussurea involucrate nano particles and preparation method and application thereof
05/05/2010CN101700262A Quality control method of andrographis paniculata dropping pills
05/05/2010CN101700247A Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s)
05/04/2010US7709669 Aspirin-triggered lipid mediators
05/04/2010US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia
05/04/2010US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis
05/04/2010US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents
05/04/2010US7709500 Chemical compounds
05/04/2010US7709489 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2-a]quinoline-2-carbonyl)-4-methylpiperazine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives
05/04/2010US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
05/04/2010US7709461 Administering an aerosol of dry polysaccharide such as heparin of given particle size diameter
05/04/2010US7709460 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality
05/04/2010US7709214 Using antibody specific blocking agents to treat and prevent infection, cell proliferative and immunosuppressive disorders
05/04/2010US7709020 Implantable device comprising phosphorus-containing macrolides
05/04/2010US7708987 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR; antitumor agents
05/04/2010CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
05/04/2010CA2427608C Condensed pyradizindione derivatives as pde inhibitors
05/04/2010CA2418395C Protein induced by homogeneous blood transfusion and dna encoding the same
05/04/2010CA2352484C Pressurised metered dose inhalers (mdi)
04/2010
04/29/2010WO2010048573A1 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
04/29/2010WO2010048564A1 Modulators of cystic fibrosis transmembrane conductance regulator
04/29/2010WO2010048384A2 Arformoterol and tiotropium compositions and methods for use
04/29/2010WO2010048087A2 Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
04/29/2010WO2010047928A2 Methods and compositions for treatment of fibrosis
04/29/2010WO2010047361A1 Pharmaceutical composition improved in absorption through intestinal tract
04/29/2010WO2010047127A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
04/29/2010WO2010047126A1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
04/29/2010WO2010046791A1 Phosphodiestarase inhibitors
04/29/2010WO2010003120A3 Antagonists of prostaglandin d2 receptors
04/29/2010WO2009143483A3 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION
04/29/2010US20100105915 Chemokine receptor binding heterocyclic compounds
04/29/2010US20100105896 Pharmaceutical compounds
04/29/2010US20100105723 5-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-b]PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS
04/29/2010US20100105704 7-(3',4'-Dialkoxyphenyl)-[1,2,4]-Triazolo[1,5-A]Pyrimidine Compounds, Process for Preparing Thereof, and Pharmaceutical Composition for Treating or Preventing Asthma, Chronic Obstructive Pulmonary Disease, Arthritis, Atopic Dermatitis, Tumor and Degenerative Brain Diseases Comprising the Same
04/29/2010US20100105701 Gyrase inhibitors and uses thereof
04/29/2010US20100105689 Novel 1,4- and 1,5-diarylsubstituted 1,2,3-triazoles useful as potassium channel modulators
04/29/2010US20100105685 S-Nitrosothiol Compounds and Related Derivatives
04/29/2010US20100105681 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
04/29/2010US20100105660 Organic compounds75074
04/29/2010US20100105611 Method of treating respiratory disorders
04/29/2010US20100105603 Methods and Preparations For Curing Clinically Ill Patients
04/29/2010US20100104665 Methods and Apparatus for Treating Rhinitis
04/29/2010US20100104632 Drug Having Regulatory Cell Ligand Contained in Liposome
04/29/2010US20100104594 Pathogen for bacterial poultry disease
04/29/2010US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
04/29/2010US20100104516 Use of flagellin to prevent and treat gram negative bacterial infection
04/29/2010CA2742042A1 Modulators of cystic fibrosis transmembrane conductance regulator
04/29/2010CA2741718A1 Modulators of cystic fibrosis transmembrane conductance regulator
04/29/2010CA2741178A1 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
04/29/2010CA2741078A1 Arformoterol and tiotropium compositions and methods for use
04/29/2010CA2740810A1 Phenanthroindolizidine compound and nf.kappa.b inhibitor containing same as active ingredient
04/29/2010CA2740807A1 Phenanthroindolizidine derivative and nf.kappa.b inhibitor containing same as active ingredient
04/29/2010CA2739882A1 Pharmaceutical composition improving intestinal absorption
04/29/2010CA2735956A1 Phosphodiestarase inhibitors
04/28/2010EP2179730A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
04/28/2010EP2179039A2 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
04/28/2010EP2178881A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors
04/28/2010EP2178549A1 Antimicrobial peptide, compositions , and methods of use
04/28/2010EP2178534A1 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
04/28/2010EP1590321B1 Aryl alkyl carbamate derivatives production and use thereof in therapy
04/28/2010EP1480615B1 Formoterol superfine formulation
04/28/2010EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof
04/28/2010EP1363640B1 Nucleic acid derivatives
04/28/2010CN1904041B Human recombination phospholipase D2, its preparation method and application in preparation medicine
04/28/2010CN1875020B Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
04/28/2010CN1733125B Pharmaceutical purpose of effective parts of immature Bitter orange or trifoliate-orange root-bark
04/28/2010CN1728988B Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
04/28/2010CN1678333B Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease
04/28/2010CN1658877B Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
04/28/2010CN1555417B Paramyxovirus vector for gene transfer to the cardiovascular system
04/28/2010CN1468307B Anti-dual integrin antibodies, compositions, methods and uses
04/28/2010CN101698060A Medicament for treating chronic pharyngitis
04/28/2010CN101698054A Preparation for treating sore throat
04/28/2010CN101698046A Lozenge for diminishing inflammation and clearing pharynx
04/28/2010CN101698030A Medicine for treating chronic nasosinusitis and preparation method thereof
04/28/2010CN101698024A Traditional Chinese medicine for treating respiratory diseases and promoting growth for swine and preparation method thereof
04/28/2010CN101698023A Chinese herbal medicine formula for treating asthma
04/28/2010CN101698012A Throat clearing and moistening health-care tea for preventing and treating chronic pharyngitis
04/28/2010CN101698004A Traditional Chinese medicine composite for treating asthma
04/28/2010CN101698000A Traditional Chinese medicine for treating allergic rhinitis
04/28/2010CN101697998A Zhenhuang tablet for treating sore throat and ulcer and sore furuncle and preparation method thereof
04/28/2010CN101697996A Chinese herbal medicinal composition for externally treating allergic rhinitis
04/28/2010CN101697965A Inhalation capsules
04/27/2010USRE41287 Cyclic agonists and antagonists of C5A receptors and G Protein-coupled receptors
04/27/2010US7705195 Screening method
04/27/2010US7705050 Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils
04/27/2010US7705015 Substituted pyrroline kinase inhibitors
04/27/2010US7704999 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
04/27/2010US7704975 Modafinil compound and cyclodextrin mixtures
04/27/2010US7704969 Transfection complexes
04/27/2010US7704960 Administering Erythromycin A having had the cladinose moiety in the 3-position removed by acidolysis to produce an antiinflammatory agent having no antibiotic properties; chronic respiratory system disorders; cytokine suppressive antiinflammatory drugs; antiarthritic agents; antiischemic agents